An Exploratory Study to Assess the Absolute Bioavailability of a Single Oral Dose of AZD9668 With Respect to an Intra-venous Microdose of [14C]AZD9668 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Alvelestat; Alvelestat
- Indications Bronchiectasis; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 08 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Nov 2010 Trial phase changed from I to IV as reported by ClinicalTrials.gov.
- 22 Jul 2010 New trial record